At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. those using finger pricking1,2Improvements were participant-led, ...
At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. fingersticks 1 ...
KPNX-TV Phoenix on MSN
There's a recall on this glucose monitor. Here's what we know
About 3 million ‘Freestyle Libre 3 and 3 plus are being recalled because they can give dangerous false readings.
With nationwide availability now underway, twiist reaches a meaningful milestone in Sequel’s mission to empower the diabetes community with more choice and a more personalized, customizable AID ...
About 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors manufactured by Abbott were recalled in November, because they might give wrong readings.
GlobalData on MSN
Abbott reports positive FreeDM2 study results for CGM
The study was carried out at 24 clinical sites across the UK and included 303 participants.
A manufacturing problem in Abbott glucose sensors for diabetes patients has been tied to at least seven deaths and hundreds ...
New data shows positive real-world impact of the world’s first and only one-year CGM, with a full year of strong patient adherence, glucometrics ...
Abbott (NYSE:ABT) today announced results from a trial demonstrating better glucose outcomes for users of continuous glucose monitors (CGMs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results